𝔖 Bobbio Scriptorium
✦   LIBER   ✦

233 The influence of age on the efficacy and tolerability of combined modality therapy in limited small cell lung cancer (L-SCLC)

✍ Scribed by Shepherd, F.A.; Siu, L.; Quon, H.; Murray, N.; Feld, R.; Payne, D.; Pater, J.; Zee, B.

Book ID
122402797
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
127 KB
Volume
18
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Results of combined-modality therapy for
Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly
✍ Steven E. Schild; Philip J. Stella; Burke J. Brooks; Sumithra Mandrekar; James A πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twice‐daily radiotherapy (BIDRT) or once‐daily radiotherapy (QDRT) resulted in a better outcome for patients with limited‐st

Efficacy and tolerability of vindesine i
Efficacy and tolerability of vindesine in the treatment of small-cell lung cancer
✍ D. A. L. Morgan πŸ“‚ Article πŸ“… 1986 πŸ› Springer 🌐 English βš– 134 KB

Eighteen patients suffering from small-cell lung cancer, all with measurable lesions, were treated with vindesine (3 mg/m2 i.v. on days 1 and 8 of a 21-day cycle). Partial responses (PR) were seen in six patients (three of whom had been previously heavily treated). Most patients tolerated the drug e